Phase III long-term study of KRP-108 -open-label, non-controlled, long-term study of KRP-108 in pediatric bronchial asthma-

Trial Profile

Phase III long-term study of KRP-108 -open-label, non-controlled, long-term study of KRP-108 in pediatric bronchial asthma-

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Sponsors Kyorin Pharmaceutical
  • Most Recent Events

    • 01 Aug 2017 Status changed from not yet recruiting to recruiting.
    • 03 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top